Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
1,3,6,8-tetrahydroxynaphthalene reductase (T4HNR) is a key enzyme in the dihydroxynaphthalene (DHN) melanin biosynthetic pathway of various pathogenic fungi, most notably Magnaporthe oryzae, the causative agent of rice blast disease (UniProt P30331). It catalyzes the NADPH-dependent reduction of 1,3,6,8-tetrahydroxynaphthalene to scytalone and 1,3,8-trihydroxynaphthalene to vermelone (PubMed: 1455900). Melanin is essential for the structural integrity and function of the fungal appressorium, providing the mechanical pressure necessary to penetrate the host plant epidermis (PubMed: 10459170). By inhibiting T4HNR, fungicides like tricyclazole and pyroquilon prevent melanin deposition, thereby rendering the fungus unable to infect the host (PubChem CID 5523). This enzyme is a member of the short-chain dehydrogenase/reductase (SDR) family and is a validated target for agricultural crop protection (PubMed: 11744303). The inhibition of this pathway is a non-fungitoxic mechanism, meaning it prevents disease without necessarily killing the fungal cells, which can reduce the selection pressure for resistance (PubMed: 12147477). However, resistance has been observed in field populations, often linked to mutations in the gene encoding the reductase (PubMed: 15643757). T4HNR is highly conserved among many ascomycete fungi that utilize the DHN-melanin pathway for virulence (PubMed: 16460375). Structural studies have revealed the binding mode of inhibitors like tricyclazole within the active site, facilitating the design of next-generation fungicides (PubMed: 1455900). Overall, T4HNR remains a critical target for managing devastating crop diseases globally.
Inhibition of the NADPH-dependent reduction of 1,3,6,8-tetrahydroxynaphthalene to scytalone, which prevents the synthesis of DHN-melanin required for fungal appressorial penetration of host plants (PubMed: 1455900).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 1,3,6,8-tetrahydroxynaphthalene reductase (T4HNR) (T4HNR).